The wearable injectors global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Wearable Injectors Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The wearable injectors market size has grown rapidly in recent years. It will grow from $8.04 billion in 2023 to $9.07 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to chronic disease management, patient convenience, technological advancements, aging population.
The wearable injectors market size is expected to see rapid growth in the next few years. It will grow to $15.23 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to personalized medicine, remote patient monitoring, drug development, chronic disease management. Major trends in the forecast period include biologics and large molecules, dual-chamber wearables, connected and smart devices, patch pump technology.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/wearable-injectors-global-market-report
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Drivers –
The rise in the number of diabetic and chronic diseases patients such as cardiovascular diseases and cancers contributed to the growth of the wearable injectors market. According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes, and by 2045, it is estimated that around 783 million adults around the world and 1 in 5 adults who are above 65 are expected to suffer from diabetes. The rise in the number of diabetes and chronic diseases patients increased the demand for the treatment of the diseases, thereby driving the wearable injectors market growth.
Market Trends –
The focus areas for many companies in the wearable injectors manufacturing market have shifted to increasing mergers and acquisitions to acquire more production capabilities. Large prime manufacturers are forming joint ventures or buying small or midsized companies to acquire new capabilities or gain access to new markets. In February 2021, Phillips-Medisize, a US-based medical device company, collaborated with Subcuject to develop a wearable osmotic bolus injector. The collaboration aims to combine Phillips-Medisize’s expertise in proprietary device platforms with Subcuject’s technology innovation and drug delivery experience to accelerate the development and commercialization of the wearable osmotic bolus injector. Subcuject is a US-based medical device company that specializes in the development of a subcutaneous wearable bolus injector.
The wearable injectors market covered in this report is segmented –
1) By Type: On-Body Injectors, Off-Body Injectors
2) By End-User: Hospitals, Clinics, Homecare setting
3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications
Get an inside scoop of the wearable injectors market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3308&type=smp
Regional Insights –
North America was the largest region in the wearable injectors market in 2023. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the wearable injectors market include Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical plc, United Therapeutics Corporation, Bühler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd, Zosano Pharma Corporation
Table of Contents
1. Executive Summary
2. Wearable Injectors Market Report Structure
3. Wearable Injectors Market Trends And Strategies
4. Wearable Injectors Market – Macro Economic Scenario
5. Wearable Injectors Market Size And Growth
…..
27. Wearable Injectors Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
